Clinical Roundup Keytruda + Lenvima demonstrate long-term survival benefit vs. sunitinib as first-line RCC treatment June 09, 2023Vol.49 No.23
Clinical Roundup Adding ribociclib to hormone therapy improves outcomes in patients with early breast cancer June 09, 2023Vol.49 No.23
Clinical Roundup HERGain study shows potential for chemotherapy-free treatment of early HER2+ breast cancer June 09, 2023Vol.49 No.23
Clinical Roundup Enhertu demonstrates durable response in patients across HER2 expressing advanced solid tumors June 09, 2023Vol.49 No.23
Clinical Roundup Keytruda + Lenvima demonstrates long-term, durable survival benefit vs. sunitinib as first-line treatment for advanced RCC in phase III trial June 02, 2023Vol.49 No.22
Clinical Roundup Preliminary results from phase I show safety and tolerability of Reqorsa + Tagrisso in NSCLC June 02, 2023Vol.49 No.22
Clinical Roundup Fox Chase study challenges assumptions about cystic renal masses June 02, 2023Vol.49 No.22
Clinical Roundup ASCO features studies on surgical techniques, immunotherapy, weight loss, racial disparities, international collaboration May 26, 2023Vol.49 No.21
Clinical Roundup JNCI commentary addresses cancer disparities in people affected by mass incarceration May 26, 2023Vol.49 No.21
